Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu

M Thomas, C Rube, M Semik, M von Eiff, F Klinke, HN Macha, L Freitag, HH Scheld, N Willich, WE Berdel, K Junker
European Respiratory Journal 1999 13: 424-429; DOI:
M Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Rube
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Semik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M von Eiff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Klinke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HN Macha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Freitag
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HH Scheld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Willich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WE Berdel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Junker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

In a trimodality treatment approach for stage III non-small cell lung cancer the prognostic impact of pretherapeutic p185neu assessment was evaluated. Fifty-four patients were admitted to chemotherapy followed by twice-daily radiation with concomittant low-dose chemotherapy and subsequent surgery. Immunohistochemical assessment of p185neu expression was performed in paraffin-embedded mediastinal lymph node metastases, by mediastinoscopy biopsy prior to therapy. Paraffin-embedded biopsies of mediastinal lymph node metastases were available in 33 cases. Seven out of eight patients with positive p185neu staining developed distant metastases, in contrast to seven out of 25 negative cases. Expression of p185neu in mediastinal lymph node metastases was a significant predictor for progression-free survival (p=0.047) and resulted mainly from significant differences in metastases-free survival (p185neu-positive versus p185neu-negative: median, 11 versus 19 months; 2- and 3-yr rates, 13% and 0% versus 40% and 32%; p=0.04). On the basis of these preliminary results it was concluded that further evaluation of p185neu expression in trials on neoadjuvant and adjuvant therapy is warranted. When the prognostic impact of p185neu in such trials with larger patient numbers is confirmed, this may contribute to the identification of stratification variables for future treatment approaches of non-small cell lung cancer.

PreviousNext
Back to top
Vol 13 Issue 2 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu
M Thomas, C Rube, M Semik, M von Eiff, F Klinke, HN Macha, L Freitag, HH Scheld, N Willich, WE Berdel, K Junker
European Respiratory Journal Feb 1999, 13 (2) 424-429;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu
M Thomas, C Rube, M Semik, M von Eiff, F Klinke, HN Macha, L Freitag, HH Scheld, N Willich, WE Berdel, K Junker
European Respiratory Journal Feb 1999, 13 (2) 424-429;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
  • Ambulatory management of secondary spontaneous pneumothorax
Show more Original Articles

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society